Skip to main content
. 2013 Jul 5;69(1):79–86. doi: 10.1093/gerona/glt101

Table 2.

Incident Cases of Limitations by Baseline MetS and Adjusted Risk of Limitations

No. at Baseline Follow-up Model 1 Model 2
2 y 4 y 7 y
% % % OR* 95% CI p Value OR 95% CI p Value
Social restriction
Baseline MetS N = 5,893 N = 5,713 N = 5,179 N = 4,243
    No 3.5 5.3 12.0 1 1
    Yes 6.5 8.5 22.0 2.83 2.13–3.75 <.0001 1.55 1.14–2.09    .006
Mobility
Baseline MetS N = 3,497 N = 3,344 N = 3,112 N = 2,624
    No 33.1 37.9 49.5 1 1
    Yes 44.0 45.5 60.2 1.90 1.54–2.35 <.0001 1.52 1.21–1.90    .0003
IADL
Baseline MetS N = 5,764 N = 5,575 N = 5,063 N = 4,150
    No 4.7 7.6 18.5 1 1
    Yes 9.0 10.5 30.5 2.55 1.98–3.27 <.0001 1.62 1.24–2.10    .0003
ADL
Baseline MetS N = 6,125 N = 5,927 N = 5,367 N = 4,349
    No 0.6 1.0 1.8 1 1
    Yes 0.8 1.4 2.9 2.00 1.07–3.77 .03 0.91 0.48–1.74 .79

Notes: ADL = basic activities of daily living; IADL = instrumental activities of daily living; MetS = metabolic syndrome; OR = odds ratio.

*Adjusted for center, baseline age, time, baseline interaction age × time, and sex.

Adjusted for center, baseline age, time, baseline interaction age × time, sex, education, income, living alone, alcohol, body mass index, smoking, cognitive impairment, visual impairment, hearing impairment, depressive symptoms, respiratory disease, cardiovascular disease, lipid-lowering treatment, and allele ε4 of the apolipoprotein E genotype.